glp-1 agonists and fertility Impact of Receptor on Male Fertility: Emerging Evidence Future Directions GLP-1 Receptor Agonists in Pregnancy

There may be reduced risk in microdosing GLP-1s, especially if youre doing it under the care of a healthcare provider (as you should)

doi: 10.1007/s11695-014-1560-z [DOI] [PubMed] [Google Scholar] 11

GLP-1 therapies are integrated into a broader regimen, and discontinuation is typically considered within the context of overall disease management

Oral GLP-1 therapies emerged as game-changers: Rybelsus (oral semaglutide) was approved for diabetes in 2019, and in December 2025 the FDA approved Wegovys first oral pill (25 mg semaglutide) for obesity ( [35] )

Selection of reported studies: Studies reported in the text and above in the table were selected according to data relevancy and currency